ES2183177T3 - Nuevos complejos de glicolipidos y su utilizacion. - Google Patents

Nuevos complejos de glicolipidos y su utilizacion.

Info

Publication number
ES2183177T3
ES2183177T3 ES97923373T ES97923373T ES2183177T3 ES 2183177 T3 ES2183177 T3 ES 2183177T3 ES 97923373 T ES97923373 T ES 97923373T ES 97923373 T ES97923373 T ES 97923373T ES 2183177 T3 ES2183177 T3 ES 2183177T3
Authority
ES
Spain
Prior art keywords
glycolipid
complex
diagnostic methods
glycolipid complexes
new glycolipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97923373T
Other languages
English (en)
Inventor
Karsten Buschard
Pam Fredman
Jan-Eric Mansson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A+ Science AB
Original Assignee
A+ Science Invest AB
A+ Science AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A+ Science Invest AB, A+ Science AB filed Critical A+ Science Invest AB
Application granted granted Critical
Publication of ES2183177T3 publication Critical patent/ES2183177T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Rehabilitation Therapy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

SE PRESENTA UN COMPLEJO ENTRE UN POLIMERO SOLUBLE EN AGUA QUE CONTIENE REGIONES HIDROFOBICAS Y UN GLICOLIPIDO ASI COMO INMUNOENSAYOS QUE UTILIZAN EL COMPLEJO COMO REACTIVO INMUNE Y PROCEDIMIENTOS DE DIAGNOSTICO QUE SE UTILIZAN EN EL CONTEXTO DE LAS NEUROPATIAS Y LA DIABETES DEPENDIENTE DE LA INSULINA. LOS PROCEDIMIENTOS DE DIAGNOSTICO EMPLEAN ANTICUERPOS ANTIGLICOLIPIDOS COMO MARCADORES. EL GLICOLIPIDO PREFERIDO ES SULFATURO.
ES97923373T 1996-05-13 1997-05-10 Nuevos complejos de glicolipidos y su utilizacion. Expired - Lifetime ES2183177T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601817A SE9601817D0 (sv) 1996-05-13 1996-05-13 Novel glycolipid complexex and their uses

Publications (1)

Publication Number Publication Date
ES2183177T3 true ES2183177T3 (es) 2003-03-16

Family

ID=20402548

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97923373T Expired - Lifetime ES2183177T3 (es) 1996-05-13 1997-05-10 Nuevos complejos de glicolipidos y su utilizacion.

Country Status (13)

Country Link
US (2) US6352831B1 (es)
EP (1) EP0928201B1 (es)
JP (1) JP2000513332A (es)
AT (1) ATE222775T1 (es)
AU (1) AU728141B2 (es)
CA (1) CA2253883A1 (es)
DE (1) DE69715014T2 (es)
DK (1) DK0928201T3 (es)
ES (1) ES2183177T3 (es)
HK (1) HK1021321A1 (es)
PT (1) PT928201E (es)
SE (1) SE9601817D0 (es)
WO (1) WO1997042974A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU750141B2 (en) * 1997-12-30 2002-07-11 A+ Science Invest Ab Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications
SE0000258D0 (sv) * 2000-01-27 2000-01-27 A & Science Invest Ab Pharmaceutical preparation and method for treatment of diabetes
US6824999B1 (en) * 2000-05-05 2004-11-30 Athena Diagnostics, Inc. Detection of antibodies to gangliosides using solid-phase reactants coated with carbonyl groups
US6599756B1 (en) * 2000-07-27 2003-07-29 Athena Diagnostics, Inc. Detection of antibodies to glycosphingolipids using solid-phase reactants coated with carbonyl groups
NZ518163A (en) * 2002-04-05 2005-04-29 Kiwi Ingenuity Ltd Embryo modified with a glycolipid to enhance implantation into the endometrium
US20110118197A1 (en) * 2005-09-29 2011-05-19 Vipin Kumar Chaturvedi Prevention of hepatic ischemic reperfusion injury by administration of sulfatides
CA2623946A1 (en) * 2005-09-29 2007-04-05 Torrey Pines Institute For Molecular Studies Sulfatides for treatment of autoimmune disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS628055A (ja) 1985-07-05 1987-01-16 Shinotesuto Kenkyusho:Kk 酵素免疫測定方法
DK84691D0 (da) * 1991-05-07 1991-05-07 Karsten Buschard Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
CA2150956A1 (en) * 1992-12-10 1994-06-23 Robert G. L. Shorr Glycolipid enzyme-polymer conjugates

Also Published As

Publication number Publication date
EP0928201A1 (en) 1999-07-14
WO1997042974A1 (en) 1997-11-20
PT928201E (pt) 2003-01-31
DE69715014T2 (de) 2004-02-26
US6352831B1 (en) 2002-03-05
DK0928201T3 (da) 2002-12-23
DE69715014D1 (de) 2002-10-02
HK1021321A1 (en) 2000-06-09
JP2000513332A (ja) 2000-10-10
US20020034769A1 (en) 2002-03-21
SE9601817D0 (sv) 1996-05-13
AU2918897A (en) 1997-12-05
CA2253883A1 (en) 1997-11-20
EP0928201B1 (en) 2002-08-28
AU728141B2 (en) 2001-01-04
ATE222775T1 (de) 2002-09-15

Similar Documents

Publication Publication Date Title
SE7510807L (sv) Till plastmaterial konvalent bundna biologiska substanser och deras anvendning i radioanalys
DE68924850D1 (de) Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren.
ES2013226A4 (es) Metodo y composiciones proveiendo quimicoluminiscencia mejorada de 1,2-dioxanos
KR950001504A (ko) 데이타 프로세싱 시스템의 사용자가 인터페이스 상의 슬라이더를 느슨하게 일군으로 만들기 위한 방법 및 장치
DE69128152D1 (de) Synthetische peptide von menschlichen papillomaviren 1, 6, 11, 16, 18, 31, 33 und 56, die nützlich in immunoassays für diagnostische zwecke sind
FI932912A (fi) Testmetod och reagensfoerpackning avsedd foer den
ES2183177T3 (es) Nuevos complejos de glicolipidos y su utilizacion.
ATE69891T1 (de) Monoklonalantikoerperabfassung fuer diagnostischen gebrauch.
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
KR900005986A (ko) 항원용액중의 보조제로서 수산화아연 또는 수산화철의 용도, 및 이러한 보조제를 함유하는 항원용액
CA2089395A1 (en) Monoclonal antibodies for detecting water treatment polymers
FI853095A0 (fi) Foerfarande foer aotervinning av en gelbildande polysackarid, aotervunnen polysackarid och gel bildad daermed.
SE7901166L (sv) Reagens for anvendning vid immunoanalys
EP0389301A3 (en) Reagent complex for immunoassay
ES458411A1 (es) Un metodo y un aparato inmunoquimico de separacion de frac- ciones libres de las combinadas en un proceso de inmunoana- lisis.
IE40645L (en) Preparations for detecting treponemal diseases such as¹syphilis comprising an antigen reagent and an azo dye.
ES516244A0 (es) Soportes de materia plastica revestidos de un segundo anticuerpo.
FI861715A (fi) Monoklonal antiurokinase-antikropp, den innehaollande matris och biokemiska testpackningar, i vilka den anvaendes.
DK398086D0 (da) Fremgangsmaade til foroegelse af oploeseligheden af immunokonjugatpraeparationer eller ukonjugeret immunoglobulin samt fremgangsmaade til nedsaettelse af intakte toksinkonjugaters toksicitet
EP0407605A4 (en) Reagent for detecting antibody corresponding to acid-fast bacterium antigen and application thereof
JPS52154520A (en) Modified antibody and its preparation
ATA366478A (de) Kunststoff/kunststoff-gleitpaarungen in tribologischen systemen, insbesondere gleit- lagern
AU647449B2 (en) Method for the immunological determination of ligands
TW373070B (en) Analysis element and method for preparing the same
KR910012711A (ko) 경도 성분 검출 방법